RT Journal Article
SR Electronic
T1 The Magnitude, Distribution Patterns, and Risk Factors of AIDS-Related Illnesses in Adults on Combined Antiretroviral Therapy in Malawi
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.14.23298518
DO 10.1101/2023.11.14.23298518
A1 Salema, Hemson Hendrix
YR 2023
UL http://medrxiv.org/content/early/2023/11/15/2023.11.14.23298518.abstract
AB This study describes the burden and spectrum of AIDS-related opportunistic diseases (ODs) in adults living with HIV (ALHIV) receiving combined antiretroviral therapy since the scale-up of free HIV treatment in Malawi. Data on AIDS-related ODs were abstracted from the 2004-2015 medical records and analysed using logistic regression models. 9,953 patients, with median age of 40 years (interquartile range (IQR): 33–48 years), of which 60.8% were females and 86.8% were within active sexual age (15-54 years), were included in the analysis. 65.1% were urban residents and 59.6% were from Southern region. 12,814 AIDS-related opportunistic episodes were extracted: 56.5% were prevalent AIDS-defining conditions and 43.5% were incident and recurrent cases. 7.7% of patients did not manifest any OD. Mycobacterial (36.3%), bacterial (20.8%), fungal (15.8%) and viral (15.1%) aetiological agents were most identified common pathogens. Tuberculosis (34.4%), bacterial pneumonia (11.2%), nontyphoid Salmonella bacteraemia (9.6%), HIV-wasting syndrome (8.9%), candidiasis (6.8%), isosporiasis (5.2%), pneumocystis pneumonia (4.2%) and cryptococcal meningitis (3.7%) were overall, most prevalent ODs. In the multivariate regression, healthcare facility types, gender, age-group, residential area, CD4 count, viral load, treatment initiation eligibility criteria and socio-economic status were identifiable risk factors of AIDS-related opportunistic diseases. The high prevalence of ODs among ALHIV in Malawi regardless of ART status requires establishing and strengthening of efficient strategies for effective prevention, early detection, and proactive management of AIDS-related ODs across all patient groups, regions, and health facilities.What this study addsThis study provides insights into the scale and magnitude, the profile, the epidemiological and geographical distribution patterns, as well as associated risk factors of AIDS-related opportunistic diseases among adults living with HIV in Malawi since the introduction and scale-up of free antiretroviral therapy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone (self-funded) - this study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study obtained ethical approval from the University of Warwick Research Ethics Committee; The Biomedical and Scientific Research Ethics Committee-[BSREC approval number: REGO-2015-1576], and from Malawi Research Ethics Committee; The National Health Sciences Research Committee in the Ministry of Health [NHSRC approval number: NHSRC # 16/3/1555]. Approval from NHSRC was granted after obtaining "Letters of No Objection" from each of the 8 data collection centres.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data generated and analysed in the current study are available from the corresponding author, HHS, upon reasonable request.